These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3100301)

  • 1. Fibronectin replacement in patients with fulminant hepatic failure.
    Hughes RD; Imawari M; Bihari D; Almasio PL; Langley PG; Williams R
    Eur J Clin Invest; 1986 Oct; 16(5):352-6. PubMed ID: 3100301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin and Kupffer cell function in fulminant hepatic failure.
    Imawari M; Hughes RD; Gove CD; Williams R
    Dig Dis Sci; 1985 Nov; 30(11):1028-33. PubMed ID: 4053913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.
    Saba TM; Blumenstock FA; Shah DM; Landaburu RH; Hrinda ME; Deno DC; Holman JM; Cho E; Dayton C; Cardarelli PM
    Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the molecular forms of fibronectin in fulminant hepatic failure.
    Almasio PL; Hughes RD; Williams R
    Hepatology; 1986; 6(6):1340-5. PubMed ID: 3098666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.
    Saba TM; Jaffe E
    Am J Med; 1980 Apr; 68(4):577-94. PubMed ID: 6768291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin in acute and subacute hepatic failure.
    Anand AC; Irshad M; Acharya SK; Gandhi BM; Joshi YK; Tandon BN
    J Clin Gastroenterol; 1989 Jun; 11(3):314-9. PubMed ID: 2754218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin in fulminant hepatic failure.
    Gonzalez-Calvin J; Scully MF; Sanger Y; Fok J; Kakkar VV; Hughes RD; Gimson AE; Williams R
    Br Med J (Clin Res Ed); 1982 Oct; 285(6350):1231-2. PubMed ID: 6812819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of fibronectin and opsonic deficiency in patients. A controlled study.
    Saba TM; Blumenstock FA; Shah DM; Kaplan JE; Cho E; Scovill W; Stratton H; Newell J; Gottlieb M; Sedransk N
    Ann Surg; 1984 Jan; 199(1):87-96. PubMed ID: 6362585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin and liver disease.
    Hughes RD; Williams R
    Hepatology; 1987; 7(4):800-1. PubMed ID: 3610052
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryoprecipitate infusion fails to improve organ function in septic shock.
    Hesselvik F; Brodin B; Carlsson C; Cedergren B; Jorfeldt L; Liedén G
    Crit Care Med; 1987 May; 15(5):475-83. PubMed ID: 3552444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the opsonic activity of fibronectin by a plasma factor lacking gelatin affinity.
    Blumenstock FA; Saba TM; Cardarelli PM; Cho E
    J Reticuloendothel Soc; 1983 Jan; 33(1):21-33. PubMed ID: 6834358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin and factor VIII-related antigen in liver cirrhosis and acute liver failure.
    Höfeler H; Klingemann HG
    J Clin Chem Clin Biochem; 1984 Jan; 22(1):15-9. PubMed ID: 6421989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of fibronectin in critically ill patients.
    Grossman JE
    Prog Clin Biol Res; 1989; 299():157-67. PubMed ID: 2657787
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of fibronectin as an opsonin in the host defence system: a case of competitive self inhibition?
    Brown RA
    Lancet; 1983 Nov; 2(8358):1058-60. PubMed ID: 6138603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gelatin on bioassayable and immunoreactive opsonic fibronectin.
    Niehaus GD; Dillon BC; Schumacker PT; Saba TM
    Proc Soc Exp Biol Med; 1981 Oct; 168(1):15-23. PubMed ID: 7323064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral regulation of plasma opsonic fibronectin levels: its role in reticuloendothelial recovery after RE blockade.
    Roccario E; Saba TM; Cho E
    Adv Shock Res; 1981; 5():57-66. PubMed ID: 7304331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic removal of 125I-DLT gelatin after burn injury: a model of soluble collagenous debris that interacts with plasma fibronectin.
    Blumenstock FA; La Celle P; Herrmannsdoerfer A; Giunta C; Minnear FL; Cho E; Saba TM
    J Leukoc Biol; 1993 Jul; 54(1):56-64. PubMed ID: 8336079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonic dysfunction secondary to plasma fibronectin depletion after aortic surgery.
    Powell JT; Poskitt KR; Irwin JT; Attanoos RL; McCollum CN
    Br J Surg; 1986 Jan; 73(1):38-40. PubMed ID: 3947871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.